GLP-1 RAs in Chronic Migraine - Top-Institutions - MDSpire

GLP-1 RAs in Chronic Migraine

Investigators evaluate health care utilization and treatment patterns vs topiramate in an active-comparator study.

  • By

  • Kathryn Wighton

  • March 3, 2026

  • 3 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Headache Medicine
    • Clinical Research

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Headache Medicine
    • Translational Research

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurology
    • Pain Medicine
    • Clinical Trials

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Headache Medicine
    • Clinical Epidemiology

  • #5

    University of Sao Paulo
    University of Sao Paulo

    Sao Paulo, SP

    Key Differentiators

    • Neurology
    • Headache Medicine
    • Clinical Research

Original Source(s)

GLP-1 RAs in Chronic Migraine

  • by Kathryn Wighton

  • March 3, 2026

Related Content

MRI May Define Two Distinct Migraine Phenotypes

Patients with greater migraine burden showed widespread connectivity changes and lower cortical volume.

The RASA2/RASA3 ortholog RasGAP1 modulates obesity-linked phenotypes and is associated with leptin-analog signaling in Drosophila

Astigmatism Up After COVID Restrictions

Researchers identified delayed corneal changes in schoolchildren that emerged after myopia rates had already increased during the pandemic.